These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 19711130)

  • 41. Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience.
    Lee B; Shinohara K; Weinberg V; Gottschalk AR; Pouliot J; Roach M; Hsu IC
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1106-12. PubMed ID: 17197119
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer.
    Aström L; Pedersen D; Mercke C; Holmäng S; Johansson KA
    Radiother Oncol; 2005 Feb; 74(2):157-61. PubMed ID: 15734203
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical results of medium dose rate brachytherapy combined with external beam radiotherapy in the treatment of advanced cervical carcinoma.
    Ordeanu C; Coza O; Gavris S; Todor N; Szilagy E; Bako M; Cernea V; Ghilezan N; Nagy V
    J BUON; 2007; 12(2):221-6. PubMed ID: 17600876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas.
    Schiefke F; Hildebrandt G; Pohlmann S; Heinicke F; Hemprich A; Frerich B
    J Craniomaxillofac Surg; 2008 Jul; 36(5):285-92. PubMed ID: 18353667
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-dose-rate brachytherapy for primary carcinomas of the oral cavity and oropharynx.
    Rudoltz MS; Perkins RS; Luthmann RW; Fracke TD; Green TM; Moye L; Wludyka P; Choi YK; Ackerman SN
    Laryngoscope; 1999 Dec; 109(12):1967-73. PubMed ID: 10591356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Brachytherapy versus surgery in carcinoma of tonsillar fossa and/or soft palate: late adverse sequelae and performance status: can we be more selective and obtain better tissue sparing?
    Levendag P; Nijdam W; Noever I; Schmitz P; van de Pol M; Sipkema D; Braat C; de Boer M; Jansen P
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):713-24. PubMed ID: 15183475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy - preliminary results.
    Jo Y; Fujii T; Hara R; Yokoyama T; Miyaji Y; Yoden E; Hiratsuka J; Nagai A
    BJU Int; 2012 Mar; 109(6):835-9. PubMed ID: 21933327
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction of 2-Gy equivalent dose and margin status in perioperative high-dose-rate brachytherapy.
    Martínez-Monge R; Cambeiro M; Moreno M; Gaztañaga M; San Julián M; Alcalde J; Jurado M
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1158-63. PubMed ID: 21353160
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic value of external beam radiation therapy in patients treated with surgical resection and intraoperative electron beam radiation therapy for locally recurrent soft tissue sarcoma: a multicentric long-term outcome analysis.
    Calvo FA; Sole CV; Cambeiro M; Montero A; Polo A; Gonzalez C; Cuervo M; San Julian M; Garcia-Sabrido JL; Martinez-Monge R
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):143-50. PubMed ID: 24331661
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Full-dose adjuvant postoperative radiation therapy for retroperitoneal sarcomas.
    Pezner RD; Liu A; Chen YJ; Smith DD; Paz IB
    Am J Clin Oncol; 2011 Oct; 34(5):511-6. PubMed ID: 21127412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Innovation in the management of soft tissue sarcomas in infants and young children: high-dose-rate brachytherapy.
    Nag S; Martínez-Monge R; Ruymann F; Jamil A; Bauer C
    J Clin Oncol; 1997 Sep; 15(9):3075-84. PubMed ID: 9294470
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Salvage wide resection with intraoperative electron beam therapy or HDR brachytherapy in the management of isolated local recurrences of soft tissue sarcomas of the extremities and the superficial trunk.
    Cambeiro M; Aristu JJ; Moreno Jimenez M; Arbea L; Ramos L; San Julian M; Azinovic I; Calvo FA; Martínez-Monge R
    Brachytherapy; 2015; 14(1):62-70. PubMed ID: 25443530
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-dose rate brachytherapy alone in postoperative soft tissue sarcomas with close or positive margins.
    Itami J; Sumi M; Beppu Y; Chuman H; Kawai A; Murakami N; Morota M; Mayahara H; Yoshimura R; Ito Y; Kagami Y
    Brachytherapy; 2010; 9(4):349-53. PubMed ID: 20692211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perioperative high-dose-rate interstitial brachytherapy combined with external beam radiation therapy for soft tissue sarcoma.
    Sharma DN; Deo SV; Rath GK; Shukla NK; Bakhshi S; Gandhi AK; Julka PK
    Brachytherapy; 2015; 14(4):571-7. PubMed ID: 25861894
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of combined external beam radiotherapy and brachytherapy on local control and wound complications in patients with high-grade soft tissue sarcomas of the extremity with positive microscopic margin.
    Alekhteyar KM; Leung DH; Brennan MF; Harrison LB
    Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):321-4. PubMed ID: 8892454
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-dose-rate brachytherapy boost for prostate cancer: Comparison of three different fractionation schemes.
    Falk AT; Demontoy S; Chamorey E; Chand ME; Gautier M; Azria D; Zaki S; Chevallier D; Cham Kee DL; Hannoun-Lévi JM
    Brachytherapy; 2017; 16(5):993-999. PubMed ID: 28754301
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The 15-year outcomes of high-dose-rate brachytherapy for radical dose escalation in patients with prostate cancer - a benchmark for high-tech external beam radiotherapy alone?
    Galalae RM; Zakikhany NH; Geiger F; Siebert FA; Bockelmann G; Schultze J; Kimmig B
    Brachytherapy; 2014; 13(2):117-22. PubMed ID: 24360880
    [TBL] [Abstract][Full Text] [Related]  

  • 58. American Brachytherapy Society (ABS) consensus statement for sarcoma brachytherapy.
    Holloway CL; Delaney TF; Alektiar KM; Devlin PM; O'Farrell DA; Demanes DJ
    Brachytherapy; 2013; 12(3):179-90. PubMed ID: 23434220
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is there a place for brachytherapy in the salvage treatment of cervical lymph node metastases of head and neck cancers?
    Bartochowska A; Skowronek J; Wierzbicka M; Leszczynska M; Szyfter W
    Brachytherapy; 2015; 14(6):933-8. PubMed ID: 26249122
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dose volume histogram constraints in patients with soft tissue sarcomas of the extremities and the superficial trunk treated with surgery and perioperative HDR brachytherapy.
    Gómez-Álvarez J; Martín Pastor S; Gimeno M; Lamo-Espinosa J; Ramos LI; Cambeiro M; Tagliaferri L; Kovacs G; Strnad V; San-Julián M; Martinez-Monge R
    Radiother Oncol; 2022 May; 170():159-164. PubMed ID: 35227732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.